Annual review of basic research on lung transplantation of China in 2024

Jier MA; Junmin ZHU; Lan ZHANG; Xiaohan JIN; Xiangyun ZHENG; Senlin HOU; Zengwei YU; Yaling LIU; Haoji YAN; Dong TIAN

Return

Annual review of basic research on lung transplantation of China in 2024

VernacularTitle:2024年中国肺移植基础研究年度盘点
Author: Jier MA ¹ ; Junmin ZHU ¹ ; Lan ZHANG ¹ ; Xiaohan JIN ¹ ; Xiangyun ZHENG ² ; Senlin HOU ² ; Zengwei YU ² ; Yaling LIU ² ; Haoji YAN ² ; Dong TIAN ^{2
,

3}
Author Information

1. West China School of Clinical Medicine, Sichuan University, Chengdu 610041, China.
2. .
3.
Publication Type:AcademicSummary
Keywords: Lung transplantation; Infection; Rejection; Immune tolerance; Ischemia-reperfusion injury; Chronic lung allograft dysfunction; Metagenomic next-generation sequencing; Primary graft dysfunction
From: Organ Transplantation 2025;16(3):386-393
CountryChina
Language:Chinese
Abstract: Lung transplantation is the optimal treatment for end-stage lung diseases and can significantly improve prognosis of the patients. However, postoperative complications such as infection, rejection, ischemia-reperfusion injury, and other challenges (like shortage of donor lungs) , limit the practical application of lung transplantation in clinical practice. Chinese research teams have been making continuous efforts and have achieved breakthroughs in basic research on lung transplantation by integrating emerging technologies and cutting-edge achievements from interdisciplinary fields, which has strongly propelled the development of this field. This article will comprehensively review the academic progress made by Chinese research teams in the field of lung transplantation in 2024, with a focus on the achievements of Chinese teams in basic research on lung transplantation. It aims to provide innovative ideas and strategies for key issues in the basic field of lung transplantation and to help China's lung transplantation cause reach a higher level.